NCT06560294 Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
| NCT ID | NCT06560294 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Glue Embolization |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-17 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-08-17 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.
Eligibility Criteria
Inclusion Criteria: * Women aged from 30 to 50 years. * Complaining from pelvic congestion syndrome. Exclusion Criteria: * Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers. * Patients who are treated with opiates to reduce pelvic pain in the period before the study. * Patient with history of contrast allergy * Patient with renal impairment * Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst * Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06560294 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 50 Years, studying Glue Embolization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06560294 currently recruiting?
Yes, NCT06560294 is actively recruiting participants. Contact the research team at mohamed.elesawy@med.tanta.edu.eg for enrollment information.
Where is the NCT06560294 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT06560294 clinical trial?
NCT06560294 is sponsored by Tanta University. The trial plans to enroll 40 participants.